CRYO CELL INTERNATIONAL INC (CCEL) Earnings Signals & AI Vibe Check

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, CRYO CELL INTERNATIONAL INC's filing signal turned negative.

Cryo-Cell International, Inc. is a pioneer in cord blood banking, founded in 1989 as the world's first private cord blood bank. The company specializes in the collection, processing, and cryogenic storage of umbilical cord blood and cord tissue stem cells for family use, alongside processing these cells for public banking. It also manufactures the PrepaCyte(R) CB Processing System, a technology for processing umbilical cord blood stem cells. With over 250,000 cord blood and cord tissue specimens stored globally through its affiliates, Cryo-Cell operates from its cGMP/cGTP-compliant facility in Oldsmar, Florida, with primary storage in Durham, North Carolina. The company's business model relies on processing and annual storage fees, with a focus on client education and market penetration.

Revenue is primarily driven by processing and storage fees for umbilical cord blood and cord tissue stem cells for family use. Additional revenue streams include sales of the PrepaCyte(R) CB Processing System and revenue from the public cord blood banking segment.